Ebola Vaccine

There have been 36 suspected cases of Ebola in Uganda and Sudan virus is the cause, the World Health Organization has said.

Survivors of the Ebola virus often have serious visual problems, and a new study helps explain why.

Health authorities do not expect a repeat of the West African outbreak, which claimed 11,000 lives.

The tool calculates the severity of an ebola case and could save lives if the epidemic returns.

The vaccine as one important tool in controlling future outbreaks of Ebola.

There is currently no vaccine available for the virus, which has killed over 11,000 people since 2014.

The deal comes days after an Ebola death in Sierra Leone put more than 100 people in quarantine.

Data from a trial in Guinea showed a vaccine was 100 percent effective.

An inhalable vaccine would have several advantages over those that come in needles.

The vaccine led the patient to develop antibodies against the Ebola virus.

Experts are warning that Ebola will return without serious investment in health services.

300 vials of the vaccine will arrive in Monrovia on Friday.

Humanitarian organization Médecins Sans Frontières will host trials by European researchers of two drugs and blood plasma therapy at its treatment centers in countries most affected by the Ebola outbreak.

"At least 5 vaccines are following closely and will be in the clinic in the first months of 2015," the WHO's Marie-Paule Kieny told reporters.

In the midst of one of the most gruesome plagues of the new century, many of the world's most advanced countries have no stocks of Ebola drugs, are tortured by the ethics of using blood from survivors and are compromised by the use of experimental treatments

Twenty volunteers will be injected with the experimental vaccine beginning next week

The WHO's ethics committee decided that untested Ebola treatments and vaccines can and should be used to treat patients in the current outbreak.